Novo Nordisk

Novo Nordisk: Prevention, digital tools and collaboration to define the future of diabetes
Pharmaforum
Tue, 08/11/20 - 11:38 am
Novo Nordisk
diabetes
digital pharma
digital medicine
Novo Nordisk axes experimental obesity drugs after success with later-stage meds
Fierce Biotech
Thu, 08/6/20 - 11:20 pm
Novo Nordisk
obesity
semaglutide
Biopharma takeovers show quantity, if not quality
EP Vantage
Mon, 07/13/20 - 11:13 am
COVID-19
pandemic
M&A
Novo Nordisk
Corvidia
Gilead Sciences
Pionyr
Alexion
Portola Pharmaceuticals
Menarini
Stemline Therapeutics
Shionogi
Tetra Therapeutics
Mylan, seeking to market Victoza generic, convinces panel to start up patent review
Fierce Pharma
Wed, 06/24/20 - 11:18 pm
Mylan
patents
generics
Novo Nordisk
Victoza
diabetes
ADA: Lilly's Trulicity tops Ozempic at keeping patients compliant, real-world data show
Fierce Pharma
Sun, 06/14/20 - 08:14 pm
ADA
diabetes
Eli Lilly
Trulicity
Novo Nordisk
Ozempic
ADA: Novo Nordisk's long-lasting insulin candidate matches Lantus in phase 2
Fierce Pharma
Sun, 06/14/20 - 08:05 pm
ADA
diabetes
Novo Nordisk
insulin icodec
Sanofi
Lantus
insulin
Novo Nordisk Strikes a $725M Deal for AstraZeneca Spinout Corvidia
Xconomy
Thu, 06/11/20 - 10:38 pm
Novo Nordisk
M&A
Corvidia
kidney disease
Big pharma heads towards important readouts
EP Vantage
Wed, 05/20/20 - 10:22 am
Ozempic
Novo Nordisk
etrolizumab
Roche
Ipatasertib
finerenone
Bayer
filgotinib
Gilead Sciences
Galapagos
Avalglucosidase alfa
Sanofi
Rinvoq
AbbVie
clinical trials
Novo's diabetes drug also appears to work in NASH
BioPharma Dive
Thu, 05/7/20 - 12:08 am
Novo Nordisk
NASH
semaglutide
Sidelined by COVID-19 pandemic, Team Novo Nordisk cyclists crank and jam on social media instead
Fierce Pharma
Wed, 05/6/20 - 12:12 pm
Novo Nordisk
pharma marketing
social media
The top pharma companies in social media
Fierce Pharma
Mon, 05/4/20 - 11:02 am
social media
Boehringer Ingelheim
AbbVie
GSK
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Genentech, Novo Nordisk and AbbVie top the list of best workplaces in biopharma
Fierce Pharma
Fri, 04/17/20 - 11:30 pm
Roche
Genentech
Novo Nordisk
AbbVie
Fortune
employees
Will Novo’s big thinking in obesity pay off?
EP Vantage
Thu, 04/16/20 - 10:32 am
Novo Nordisk
obesity
Ozempic
AM833
clinical trials
Novo Nordisk expands 90-day free insulin program to workers affected by COVID-19
Fierce Pharma
Wed, 04/15/20 - 11:08 pm
Novo Nordisk
insulin
diabetes
COVID-19
Novo Nordisk Pauses 3 Clinical Trials Testing Hemophilia Therapy
Xconomy
Mon, 03/16/20 - 11:50 pm
Novo Nordisk
clinical trials
concizumab
hemophilia
Insights into how Novo Nordisk's Saxenda cuts food cravings may inspire new obesity drugs
Fierce Biotech
Thu, 03/5/20 - 11:05 pm
Novo Nordisk
Saxenda
obesity
food cravings
Novo bids for recognition in the year of NASH
EP Vantage
Thu, 03/5/20 - 10:39 am
NASH
Novo Nordisk
Ozempic
Blockbusters in waiting: drug launches to watch in 2020
Pharmaforum
Mon, 02/17/20 - 11:33 pm
drug launches
Biohaven
rimegepant
Novartis
ofatumumab
Celgene
ozanimod
Akebia Therapeutics
vadadustat
Biomarin
valrox
Gilead Sciences
filgotinib
Novo Nordisk
oral semaglutide
inclisiran
Immunomedics
sacituzumab govitecan
AstraZeneca
Enhertu
Bristol-Myers Squibb
liso-cel
How a cocktail of existing drugs could regenerate insulin-producing cells in diabetes
Fierce Biotech
Thu, 02/13/20 - 10:44 am
diabetes
insulin
Mt Sinai
Novo Nordisk
Ozempic
Rybelsus
Victoza
Eli Lilly
Trulicity
AstraZeneca
Bydureon
Lilly, Novo Nordisk Fight Insulin Biosimilars With Tweaks to FDA Draft Guidance
RAPS.org
Wed, 02/12/20 - 12:00 am
diabetes
insulin
biosimilars
Eli Lilly
Novo Nordisk
FDA
competition

Pages